300804 广康生化
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.3653.17717.22120.90632.470
总资产报酬率 ROA (%)0.9622.17411.33513.79721.068
投入资产回报率 ROIC (%)1.0302.36112.83915.94724.633

边际利润分析
销售毛利率 (%)24.92724.03029.28131.60638.584
营业利润率 (%)11.7696.28616.10518.33219.496
息税前利润/营业总收入 (%)12.3097.75215.75318.76619.885
净利润/营业总收入 (%)9.9066.07514.57415.66015.195

收益指标分析
经营活动净收益/利润总额(%)108.00895.130103.847102.330110.246
价值变动净收益/利润总额(%)7.65313.2710.000-0.0170.000
营业外收支净额/利润总额(%)-2.108-1.657-2.663-2.849-8.324

偿债能力分析
流动比率 (X)2.0642.0401.2821.3741.659
速动比率 (X)1.7591.7210.8900.8511.013
资产负债率 (%)29.13129.78935.10133.03934.826
带息债务/全部投入资本 (%)23.30624.14924.91120.43522.072
股东权益/带息债务 (%)325.650310.606292.624375.006343.711
股东权益/负债合计 (%)243.002235.690184.890202.674186.312
利息保障倍数 (X)15.7214.943239.80019.92510.534

营运能力分析
应收账款周转天数 (天)85.658100.65161.72848.05667.639
存货周转天数 (天)102.262118.40381.800105.986182.785